GRM5 and myeloid sarcoma: Taken together, while mGluR5 expression in astrocytes increased in the PPWM and DMWM compared to NAWM, its expression in OPCs was notably reduced in the DMWM, suggesting a cell-type specific shift in mGluR5 expression within MS lesions.